Effects of Pioglitazine (Actos®) or Sitagliptin (Januvia®) in Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Monotherapy

被引：0
|
作者：
Handayani, Olivia
Tandra, Hans
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A182 / A182
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of the addition of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sitagliptin: The VERTIS SITA2 placebo-controlled randomized study
    Dagogo-Jack, Samuel
    Liu, Jie
    Eldor, Roy
    Amorin, Guillermo
    Johnson, Jeremy
    Hille, Darcy
    Liao, Yuqin
    Huyck, Susan
    Golm, Gregory
    Terra, Steven G.
    Mancuso, James P.
    Engel, Samuel S.
    Lauring, Brett
    DIABETES OBESITY & METABOLISM, 2018, 20 (03): : 530 - 540
  • [42] Efficacy and safety of ertugliflozin in patients with type 2 diabetes inadequately controlled with metformin monotherapy: VERTIS MET trial
    Charbonnel, B.
    Pascu, R.
    Frias, J.
    Pall, D.
    Saur, D.
    Darekar, A.
    Huyck, S.
    Shi, H.
    Lauring, B.
    Terra, S.
    Rosenstock, J.
    DIABETOLOGIA, 2017, 60 : S406 - S407
  • [43] Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study
    Seck, T.
    Nauck, M.
    Sheng, D.
    Sunga, S.
    Davies, M. J.
    Stein, P. P.
    Kaufman, K. D.
    Amatruda, J. M.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (05) : 562 - 576
  • [44] The Efficacy and Safety of Imeglimin as Add-On Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy
    Fouqueray, Pascale
    Pirags, Valdis
    Inzucchi, Silvio
    Bailey, Clifford J.
    Schernthaner, Guntram
    Diamant, Michaela
    Lebovitz, Harold E.
    DIABETES, 2012, 61 : A257 - A257
  • [45] Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes
    Aschner, P.
    Katzeff, H. L.
    Guo, H.
    Sunga, S.
    Williams-Herman, D.
    Kaufman, K. D.
    Goldstein, B. J.
    DIABETES OBESITY & METABOLISM, 2010, 12 (03): : 252 - 261
  • [46] Safety Profiles of Sitagliptin and Metformin as Monotherapy for Type 2 Diabetes: A Pooled Analysis
    Katzeff, Harvey L.
    Engel, Samuel S.
    Wang, Hongwei
    Langdon, Ronald B.
    Williams-Herman, Debora
    Kaufman, Keith D.
    Goldstein, Barry J.
    DIABETES, 2010, 59 : A570 - A571
  • [47] Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise
    Stenlof, K.
    Cefalu, W. T.
    Kim, K. -A.
    Alba, M.
    Usiskin, K.
    Tong, C.
    Canovatchel, W.
    Meininger, G.
    DIABETES OBESITY & METABOLISM, 2013, 15 (04): : 372 - 382
  • [48] The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy
    Fouqueray, Pascale
    Pirags, Valdis
    Inzucchi, Silvio E.
    Bailey, Clifford J.
    Schernthaner, Guntram
    Diamant, Michaela
    Lebovitz, Harold E.
    DIABETES CARE, 2013, 36 (03) : 565 - 568
  • [49] The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus
    Reasner, C.
    Olansky, L.
    Seck, T. L.
    Williams-Herman, D. E.
    Chen, M.
    Terranella, L.
    Johnson-Levonas, A. O.
    Kaufman, K. D.
    Goldstein, B. J.
    DIABETES OBESITY & METABOLISM, 2011, 13 (07): : 644 - 652
  • [50] Efficacy and Safety of Saxagliptin Add-on to Metformin Compared with Acarbose Add-on to Metformin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Metformin Monotherapy
    Du, Jin
    Liang, Li
    Fang, Hui
    Xu, Fengmei
    Li, Wei
    Shen, Liya
    Mu, Yiming
    DIABETES, 2016, 65 : A293 - A293
12345